PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer.

Yearley, Jennifer H; Gibson, Christopher; Yu, Ni; Moon, Christina; Murphy, Erin; Juco, Jonathan; Lunceford, Jared; Cheng, Jonathan; Chow, Laura Q M; Seiwert, Tanguy Y; Handa, Masahisa; Tomassini, Joanne E; McClanahan, Terrill

Yearley, Jennifer H; Gibson, Christopher; Yu, Ni; Moon, Christina; Murphy, Erin; Juco, Jonathan; Lunceford, Jared; Cheng, Jonathan; Chow, Laura Q M; Seiwert, Tanguy Y; Handa, Masahisa; Tomassini, Joanne E; McClanahan, Terrill.

Affiliation

Yearley JH; Merck & Co., Inc., Kenilworth, New Jersey. jennifer.yearley@merck.com.
Gibson C; University of Pennsylvania, Philadelphia, Pennsylvania.
Yu N; Merck & Co., Inc., Kenilworth, New Jersey.
Moon C; Merck & Co., Inc., Kenilworth, New Jersey.
Murphy E; Merck & Co., Inc., Kenilworth, New Jersey.
Juco J; Merck & Co., Inc., Kenilworth, New Jersey.
Lunceford J; Merck & Co., Inc., Kenilworth, New Jersey.
Cheng J; Merck & Co., Inc., Kenilworth, New Jersey.
Chow LQM; University of Washington, Seattle, Washington.
Seiwert TY; University of Chicago, Chicago, Illinois.
Handa M; Merck & Co., Inc., Kenilworth, New Jersey.
Tomassini JE; Merck & Co., Inc., Kenilworth, New Jersey.
McClanahan T; Merck & Co., Inc., Kenilworth, New Jersey.

Clin Cancer Res ; 23(12): 3158-3167, 2017 Jun 15.

Article in En | MEDLINE | ID: mdl-28619999

Subject(s)

Carcinoma, Squamous Cell/drug therapy; Head and Neck Neoplasms/drug therapy; Immunotherapy; Programmed Cell Death 1 Ligand 2 Protein/antagonists & inhibitors; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized/administration & dosage; Carcinoma, Squamous Cell/genetics; Carcinoma, Squamous Cell/immunology; Carcinoma, Squamous Cell/pathology; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms/genetics; Head and Neck Neoplasms/immunology; Head and Neck Neoplasms/pathology; Humans; Male; Middle Aged; Programmed Cell Death 1 Ligand 2 Protein/genetics; Programmed Cell Death 1 Ligand 2 Protein/immunology; Programmed Cell Death 1 Receptor/immunology; Squamous Cell Carcinoma of Head and Neck

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Programmed Cell Death 1 Ligand 2 Protein / Programmed Cell Death 1 Receptor / Head and Neck Neoplasms / Immunotherapy Type of study: Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google